BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Höie O, Schouten LJ, Wolters FL, Solberg IC, Riis L, Mouzas IA, Politi P, Odes S, Langholz E, Vatn M, Stockbrügger RW, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 2007;56:497-503. [PMID: 17028127 DOI: 10.1136/gut.2006.101519] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Con D, Jackson B, Gray K, De Cruz P. eHealth for inflammatory bowel disease self-management - the patient perspective. Scand J Gastroenterol 2017;52:973-80. [PMID: 28598210 DOI: 10.1080/00365521.2017.1333625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
2 Sjöberg D, Holmström T, Larsson M, Nielsen AL, Holmquist L, Ekbom A, Rönnblom A. Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE). J Crohns Colitis 2013;7:e351-7. [PMID: 23491313 DOI: 10.1016/j.crohns.2013.02.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
3 Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014;7:113-120. [PMID: 25075198 DOI: 10.2147/jir.s65979] [Cited by in Crossref: 172] [Cited by in F6Publishing: 81] [Article Influence: 24.6] [Reference Citation Analysis]
4 Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, Ventura A. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168:149-155. [PMID: 18546019 DOI: 10.1007/s00431-008-0721-2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
5 Con D, De Cruz P. Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools. JMIR Mhealth Uhealth. 2016;4:e13. [PMID: 26831935 DOI: 10.2196/mhealth.4874] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
6 Wanderås MH, Moum BA, Høivik ML, Hovde &. Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies. World J Gastrointest Pharmacol Ther 2016; 7(2): 235-241 [PMID: 27158539 DOI: 10.4292/wjgpt.v7.i2.235] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
7 Vatn MH, Sandvik AK. Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015;50:748-62. [DOI: 10.3109/00365521.2015.1033000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
8 Leal-valdivieso C, Naves JE, Mañosa M, Zabana Y, Cabré E, Domènech E. Hipertensión portal en pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2010;33:297-302. [DOI: 10.1016/j.gastrohep.2009.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Naves JE, Domènech E. Amiloidosis sistémica en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2012;35:259-65. [DOI: 10.1016/j.gastrohep.2011.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. J Can Assoc Gastroenterol 2019;2:S73-80. [PMID: 31294387 DOI: 10.1093/jcag/gwy053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
11 Selinger CP, Andrews JM, Titman A, Norton I, Jones DB, Mcdonald C, Barr G, Selby W, Leong RW. Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2014;12:644-50. [DOI: 10.1016/j.cgh.2013.05.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
12 Jussila A, Virta LJ, Pukkala E, Färkkilä MA. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. J Crohns Colitis. 2014;8:1088-1096. [PMID: 24630486 DOI: 10.1016/j.crohns.2014.02.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
13 Vatn MH. Natural history and complications of IBD. Curr Gastroenterol Rep. 2009;11:481-487. [PMID: 19903424 DOI: 10.1007/s11894-009-0073-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
14 Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol. 2018;16:343-356.e3. [PMID: 28625817 DOI: 10.1016/j.cgh.2017.06.016] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 29.0] [Reference Citation Analysis]
15 Rönnblom A, Holmström T, Tanghöj H, Karlbom U, Thörn M, Sjöberg D. Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009. Scand J Gastroenterol 2016;51:1339-44. [PMID: 27356846 DOI: 10.1080/00365521.2016.1200141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
16 Sun H, Tian F. Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis. Eur J Prev Cardiolog 2018;25:1623-31. [DOI: 10.1177/2047487318792952] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
17 Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group. Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study. J Crohns Colitis. 2018;12:811-818. [PMID: 29617750 DOI: 10.1093/ecco-jcc/jjy040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 14.3] [Reference Citation Analysis]
18 Kelso M, Feagins LA. Can Smartphones Help Deliver Smarter Care for Patients With Inflammatory Bowel Disease? Inflamm Bowel Dis. 2018;24:1453-1459. [PMID: 29868764 DOI: 10.1093/ibd/izy162] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
19 Miehsler W, Novacek G, Wenzl H, Vogelsang H, Knoflach P, Kaser A, Dejaco C, Petritsch W, Kapitan M, Maier H. A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis. 2010;4:221-256. [PMID: 21122513 DOI: 10.1016/j.crohns.2009.12.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
20 Langholz E. Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol. 2010;3:77-86. [PMID: 21180592 DOI: 10.1177/1756283x10361304] [Cited by in Crossref: 52] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
21 Solberg F, Ohlsson B. Microscopic colitis and its associations with complications observed in classic inflammatory bowel disease: a systematic review. Scand J Gastroenterol 2020;55:312-20. [PMID: 32182146 DOI: 10.1080/00365521.2020.1739325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Tian Y, Wang K, Wang Z, Li N, Ji G. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice. Carcinogenesis 2013;34:1593-600. [PMID: 23471883 DOI: 10.1093/carcin/bgt088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
23 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
24 Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, Henriksen M, Høie O, Jahnsen J, Hoff G, Moum B, Bernklev T. Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study. Inflamm Bowel Dis 2016;22:1679-87. [PMID: 27206016 DOI: 10.1097/MIB.0000000000000806] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 7.3] [Reference Citation Analysis]
25 Rönnblom A, Karlbom U. Treatment and outcome of ulcerative colitis during the first 10 years after diagnosis in a prospectively followed population-based cohort. Scand J Gastroenterol 2021;56:403-9. [PMID: 33577739 DOI: 10.1080/00365521.2021.1882553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Höie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, Odes S, Mouzas IA, Beltrami M, Langholz E, Stockbrügger R, Vatn M, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007;102:1692-701. [PMID: 17555460 DOI: 10.1111/j.1572-0241.2007.01265.x] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 10.3] [Reference Citation Analysis]
27 Malik TA. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am. 2015;95:1105-1122, v. [PMID: 26596917 DOI: 10.1016/j.suc.2015.07.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 11.7] [Reference Citation Analysis]
28 Annese V, Duricova D, Gower-rousseau C, Jess T, Langholz E. Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO. ECCOJC 2016;10:216-25. [DOI: 10.1093/ecco-jcc/jjv190] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 11.7] [Reference Citation Analysis]
29 Peneau A, Savoye G, Turck D, Dauchet L, Fumery M, Salleron J, Lerebours E, Ligier K, Vasseur F, Dupas JL, Mouterde O, Spyckerelle C, Djeddi D, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol 2013;108:1647-53. [PMID: 23939626 DOI: 10.1038/ajg.2013.242] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
30 Bernstein CN, Nugent Z, Targownik LE, Singh H, Lix LM. Predictors and risks for death in a population-based study of persons with IBD in Manitoba. Gut 2015;64:1403-11. [PMID: 25227522 DOI: 10.1136/gutjnl-2014-307983] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
31 Yorulmaz E, Adali G, Yorulmaz H, Ulasoglu C, Tasan G, Tuncer I. Metabolic syndrome frequency in inflammatory bowel diseases. Saudi J Gastroenterol. 2011;17:376-382. [PMID: 22064334 DOI: 10.4103/1319-3767.87177] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
32 Manninen P, Karvonen AL, Huhtala H, Rasmussen M, Salo M, Mustaniemi L, Pirttiniemi I, Collin P. Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis. 2012;6:524-528. [PMID: 22398058 DOI: 10.1016/j.crohns.2011.10.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
33 Marín L, Mañosa M, Garcia-Planella E, Gordillo J, Zabana Y, Cabré E, Domènech E. Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol 2013;48:713-20. [PMID: 23124604 DOI: 10.1007/s00535-012-0700-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
34 D’Andrea N, Vigliarolo R, Sanguinetti CM. Respiratory involvement in inflammatory bowel diseases. Multidiscip Respir Med. 2010;5:173-182. [PMID: 22958334 DOI: 10.1186/2049-6958-5-3-173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
35 Spencer EA, Davis SM, Mack DR, Boyle BM, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz JF, Baker SS, Rosh JR, Baldassano RN, Oliva-Hemker M, Pfefferkorn MD, Otley AR, Heyman MB, Noe JD, Patel AS, Rufo PA, Alison Marquis M, Walters TD, Collins MH, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC; PROTECT Study Group. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children. Inflamm Bowel Dis 2018;24:1335-43. [PMID: 29718391 DOI: 10.1093/ibd/izy009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
36 Odes S, Vardi H, Friger M, Esser D, Wolters F, Moum B, Waters H, Elkjaer M, Bernklev T, Tsianos E, O'Morain C, Stockbrügger R, Munkholm P, Langholz E. Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis. Aliment Pharmacol Ther 2010;31:735-44. [PMID: 20047578 DOI: 10.1111/j.1365-2036.2009.04228.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
37 Fumery M, Xiaocang C, Dauchet L, Gower-rousseau C, Peyrin-biroulet L, Colombel J. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies. Journal of Crohn's and Colitis 2014;8:469-79. [DOI: 10.1016/j.crohns.2013.09.021] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 12.6] [Reference Citation Analysis]
38 Bewtra M, Kaiser LM, TenHave T, Lewis JD. Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis. 2013;19:599-613. [PMID: 23388544 DOI: 10.1097/mib.0b013e31827f27ae] [Cited by in Crossref: 73] [Cited by in F6Publishing: 29] [Article Influence: 9.1] [Reference Citation Analysis]
39 Serra I, Oller B, Mañosa M, Naves JE, Zabana Y, Cabré E, Domènech E. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome. J Crohns Colitis. 2010;4:269-274. [PMID: 21122515 DOI: 10.1016/j.crohns.2009.11.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
40 Lee HS, Choe J, Kim SO, Lee SH, Lee HJ, Seo H, Kim GU, Seo M, Song EM, Hwang SW. Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study. J Gastroenterol Hepatol. 2017;32:782-788. [PMID: 27637573 DOI: 10.1111/jgh.13596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Søgaard KK, Cronin-Fenton DP, Pedersen L, Sørensen HT, Lash TL. Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study. Inflamm Bowel Dis. 2008;14:519-525. [PMID: 18069672 DOI: 10.1002/ibd.20341] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
42 Caini S, Bagnoli S, Palli D, Saieva C, Ceroti M, Bendinelli B, Assedi M, Masala G. Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010. Dig Liver Dis. 2016;48:1162-1167. [PMID: 27481588 DOI: 10.1016/j.dld.2016.07.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
43 Levy M, Rizansky A. Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism. Eur J Health Econ 2014;15:143-56. [DOI: 10.1007/s10198-013-0461-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A. Clinical course of ulcerative colitis. Dig Liver Dis. 2008;40 Suppl 2:S247-S252. [PMID: 18598996 DOI: 10.1016/s1590-8658(08)60533-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
45 Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:942-951. [PMID: 25687629 DOI: 10.3109/00365521.2015.1014407] [Cited by in Crossref: 186] [Cited by in F6Publishing: 162] [Article Influence: 31.0] [Reference Citation Analysis]
46 Nagahori M, Hyun SB, Totsuka T, Okamoto R, Kuwahara E, Takebayashi T, Naganuma M, Watanabe M. Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J Gastroenterol. 2010;45:1008-1013. [PMID: 20414788 DOI: 10.1007/s00535-010-0247-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
47 Romberg-Camps M, Kuiper E, Schouten L, Kester A, Hesselink-van de Kruijs M, Limonard C, Bos R, Goedhard J, Hameeteman W, Wolters F. Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort. Inflamm Bowel Dis. 2010;16:1397-1410. [PMID: 20027652 DOI: 10.1002/ibd.21189] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
48 van den Heuvel TR, Jonkers DM, Jeuring SF, Romberg-camps MJ, Oostenbrug LE, Zeegers MP, Masclee AA, Pierik MJ. Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL). International Journal of Epidemiology 2017;46:e7-e7. [DOI: 10.1093/ije/dyv088] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
49 Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis. 2014;20:36-46. [PMID: 24252978 DOI: 10.1097/01.mib.0000436277.13917.c4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 19] [Article Influence: 8.4] [Reference Citation Analysis]
50 Bitton A, Vutcovici M, Sewitch M, Suissa S, Brassard P. Mortality Trends in Crohnʼs Disease and Ulcerative Colitis: A Population-based Study in Québec, Canada. Inflammatory Bowel Diseases 2016;22:416-23. [DOI: 10.1097/mib.0000000000000608] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 6.4] [Reference Citation Analysis]
51 Selinger CP, Leong RW. Mortality from inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18:1566-1572. [PMID: 22275300 DOI: 10.1002/ibd.22871] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
52 Rocchi A, Benchimol EI, Bernstein CN, Bitton A, Feagan B, Panaccione R, Glasgow KW, Fernandes A, Ghosh S. Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol. 2012;26:811-817. [PMID: 23166905 DOI: 10.1155/2012/984575] [Cited by in Crossref: 158] [Cited by in F6Publishing: 161] [Article Influence: 19.8] [Reference Citation Analysis]
53 Odes S. How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol 2008; 14(43): 6641-6647 [PMID: 19034966 DOI: 10.3748/wjg.14.6641] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]